Last reviewed · How we verify
Methylconalamin for Injection
At a glance
| Generic name | Methylconalamin for Injection |
|---|---|
| Sponsor | Wanbangde Pharmaceutical Group Co., LTD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of WP205 in Healthy Participants (PHASE1)
- Bioequivalence Study of WP205 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |